Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoproliferative Disorders × Whole-Body Irradiation × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 64 Precursor Cell Lymphoblastic Leukemia-Lymphoma 54 Myelodysplastic Syndromes 51 Leukemia, Lymphocytic, Chronic, B-Cell 49 Lymphoma, Non-Hodgkin 47 Multiple Myeloma 45 Leukemia 44 Hodgkin Disease 44 Lymphoma, Mantle-Cell 39 Lymphoma 38 Lymphoma, Follicular 34 Lymphoma, B-Cell, Marginal Zone 32 Burkitt Lymphoma 32 Lymphoma, Large B-Cell, Diffuse 31 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 31 Myeloproliferative Disorders 29 Lymphoma, Large-Cell, Immunoblastic 25 Leukemia, Myelomonocytic, Chronic 25 Congenital Abnormalities 23 Leukemia, Myeloid, Chronic-Phase 22 Waldenstrom Macroglobulinemia 21 Leukemia, Myeloid, Accelerated Phase 21 Hematologic Neoplasms 21 Primary Myelofibrosis 19 Dendritic Cell Sarcoma, Interdigitating 18 Blast Crisis 18 Anemia, Refractory, with Excess of Blasts 18 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 16 Lymphoma, Large-Cell, Anaplastic 16 Neoplasms, Plasma Cell 15

Interventions

blinatumomab 4 Rituximab 3 ponatinib 2 Vorinostat 2 Vincristine 2 Prednisone 2 Ifosfamide 2 Etoposide 2 Doxorubicin 2 Cyclophosphamide 2 Brentuximab Vedotin 2 Bortezomib 2 tetulomab tetraxetan lu-177 1 pegaspargase 1 ibritumomab tiuxetan 1 cobomarsen 1 asparaginase erwinia chrysanthemi recombinant 1 acalabrutinib 1 Methotrexate 1 Melphalan 1 Lutetium 1 KW-2478 1 Imatinib Mesylate 1 Hsp90 inhibitor KU757 1 Dexamethasone 1 Daunorubicin 1 Cytarabine 1 Carmustine 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡